I know. How many biotech CEO's go in front of their investors and say, "We are positioning ourselves to be bought out. We don't want to remain independent."
At this point, I don't see a better fit than MRK. The price part is the real question. I can't see HB selling for less than $20. That's a market cap of about 2.3 bil. If Rida makes it past this crucial point, I could see it happening by the spring.